Harold Sheedlo2019-08-222019-08-222008-05-012013-11-22https://hdl.handle.net/20.500.12503/27757The debate on the flaws and challenges faced by the Institutional Review Board (IRB) has been going on from its inception. The Office of Inspector General (OIG) in the department of Health and Human Services along with the FDA have reported on the current situation calling upon experts to find solutions to the laborious and inefficient human subject protection protocol review system. In spite of the emergence of thousands of IRB' s and newer proposed models of review systems, the current system still remains inefficient. This is a problem faced in all countries and there is an overwhelming need for an efficient, ethically equipped, and standard system to review, regulate and monitor clinical research. A national standardized clinical research review board (CRRB) would enable in safely securing research and its subjects and advance science and ethics.application/pdfenHealth Services ResearchLaboratory and Basic Science ResearchMedicine and Health SciencesInstitutional Review BoardsIRSHealth and Human ServicesFDAsystemefficienciesThesis